147 related articles for article (PubMed ID: 32926911)
1. NTCP model for hypothyroidism after supraclavicular-directed radiation therapy for breast cancer.
Huang H; Roberson J; Hou W; Mani K; Valentine E; Ryu S; Stessin A
Radiother Oncol; 2021 Jan; 154():87-92. PubMed ID: 32926911
[TBL] [Abstract][Full Text] [Related]
2. Thyroid volume changes following adjuvant radiation therapy for breast cancer.
Roberson J; Huang H; Noldner C; Hou W; Mani K; Valentine E; Ryu S; Stessin A
Clin Transl Radiat Oncol; 2023 Mar; 39():100566. PubMed ID: 36582422
[TBL] [Abstract][Full Text] [Related]
3. Radiation-induced hypothyroidism in patients with breast cancer: a retrospective analysis of 243 cases.
Kanyilmaz G; Aktan M; Koc M; Demir H; Demir LS
Med Dosim; 2017 Autumn; 42(3):190-196. PubMed ID: 28502654
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric predictors of hypothyroidism in oropharyngeal cancer patients treated with intensity-modulated radiation therapy.
Chyan A; Chen J; Shugard E; Lambert L; Quivey JM; Yom SS
Radiat Oncol; 2014 Dec; 9():269. PubMed ID: 25476839
[TBL] [Abstract][Full Text] [Related]
5. Development of multivariate NTCP models for radiation-induced hypothyroidism: a comparative analysis.
Cella L; Liuzzi R; Conson M; D'Avino V; Salvatore M; Pacelli R
Radiat Oncol; 2012 Dec; 7():224. PubMed ID: 23270411
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric comparison of conventional and forward-planned intensity-modulated techniques for comprehensive locoregional irradiation of post-mastectomy left breast cancers.
Cavey ML; Bayouth JE; Endres EJ; Pena JM; Colman M; Hatch S
Med Dosim; 2005; 30(2):107-16. PubMed ID: 15922178
[TBL] [Abstract][Full Text] [Related]
7. Should we consider thyroid gland as an organ at risk in carcinoma breast patients receiving adjuvant radiation by conformal technique? A single institute dosimetric study.
Madisetty A; Suryadevara A; Chinta SK; Vuppu S; R Marella VR
Indian J Cancer; 2020; 57(4):393-397. PubMed ID: 33078745
[TBL] [Abstract][Full Text] [Related]
8. Development of a normal tissue complication probability (NTCP) model for radiation-induced hypothyroidism in nasopharyngeal carcinoma patients.
Luo R; Wu VWC; He B; Gao X; Xu Z; Wang D; Yang Z; Li M; Lin Z
BMC Cancer; 2018 May; 18(1):575. PubMed ID: 29776390
[TBL] [Abstract][Full Text] [Related]
9. Hypothyroidism after primary radiotherapy for head and neck squamous cell carcinoma: normal tissue complication probability modeling with latent time correction.
Rønjom MF; Brink C; Bentzen SM; Hegedüs L; Overgaard J; Johansen J
Radiother Oncol; 2013 Nov; 109(2):317-22. PubMed ID: 23891099
[TBL] [Abstract][Full Text] [Related]
10. Normal tissue complication probability models of hypothyroidism after radiotherapy for breast cancer.
Park YI; Cho MS; Chang JS; Kim JS; Kim YB; Lee IJ; Hong CS; Choi SH
Clin Transl Radiat Oncol; 2024 Mar; 45():100734. PubMed ID: 38317677
[TBL] [Abstract][Full Text] [Related]
11. Effect of dose constraint on the thyroid gland during locoregional intensity-modulated radiotherapy in breast cancer patients.
Haciislamoglu E; Canyilmaz E; Gedik S; Aynaci O; Serdar L; Yoney A
J Appl Clin Med Phys; 2019 Jul; 20(7):135-141. PubMed ID: 31231982
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric Evaluation of Different Intensity-Modulated Radiotherapy Techniques for Breast Cancer After Conservative Surgery.
Zhang F; Wang Y; Xu W; Jiang H; Liu Q; Gao J; Yao B; Hou J; He H
Technol Cancer Res Treat; 2015 Oct; 14(5):515-23. PubMed ID: 25311257
[TBL] [Abstract][Full Text] [Related]
13. Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin's lymphoma.
Cella L; Conson M; Caterino M; De Rosa N; Liuzzi R; Picardi M; Grimaldi F; Solla R; Farella A; Salvatore M; Pacelli R
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1802-8. PubMed ID: 21514076
[TBL] [Abstract][Full Text] [Related]
14. External validation of a normal tissue complication probability model for radiation-induced hypothyroidism in an independent cohort.
Rønjom MF; Brink C; Bentzen SM; Hegedüs L; Overgaard J; Petersen JB; Primdahl H; Johansen J
Acta Oncol; 2015; 54(9):1301-9. PubMed ID: 26248025
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a Normal Tissue Complication Probability Model for Lymphedema After Radiation Therapy in Breast Cancer.
Park YI; Chang JS; Ko H; Im SH; Kim JS; Byun HK; Kim YB; Jung W; Kim K; Hong CS
Int J Radiat Oncol Biol Phys; 2023 Aug; 116(5):1218-1225. PubMed ID: 36739918
[TBL] [Abstract][Full Text] [Related]
16. Variation of normal tissue complication probability (NTCP) estimates of radiation-induced hypothyroidism in relation to changes in delineation of the thyroid gland.
Rønjom MF; Brink C; Lorenzen EL; Hegedüs L; Johansen J
Acta Oncol; 2015; 54(8):1188-94. PubMed ID: 25629441
[TBL] [Abstract][Full Text] [Related]
17. A prospective cohort study on radiation-induced hypothyroidism: development of an NTCP model.
Boomsma MJ; Bijl HP; Christianen ME; Beetz I; Chouvalova O; Steenbakkers RJ; van der Laan BF; Wolffenbuttel BH; Oosting SF; Schilstra C; Langendijk JA
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e351-6. PubMed ID: 22717243
[TBL] [Abstract][Full Text] [Related]
18. Is thyroid gland an organ at risk in breast cancer patients treated with locoregional radiotherapy? Results of a pilot study.
Tunio MA; Al Asiri M; Bayoumi Y; Stanciu LG; Al Johani N; Al Saeed EF
J Cancer Res Ther; 2015; 11(4):684-9. PubMed ID: 26881502
[TBL] [Abstract][Full Text] [Related]
19. A multivariable normal tissue complication probability model for predicting radiation-induced hypothyroidism in nasopharyngeal carcinoma patients in the modern radiotherapy era.
Wongwattananard S; Prayongrat A; Srimaneekarn N; Hayter A; Sophonphan J; Kiatsupaibul S; Veerabulyarith P; Rakvongthai Y; Ritlumlert N; Kitpanit S; Kannarunimit D; Lertbutsayanukul C; Chakkabat C
J Radiat Res; 2024 Jan; 65(1):119-126. PubMed ID: 37996086
[TBL] [Abstract][Full Text] [Related]
20. Dose-volume predictors of post-radiation primary hypothyroidism in head and neck cancer: A systematic review.
Chow JCH; Cheung KM; Cheung GTC; Tam AHP; Lui JCF; Lee FKH; Au KH; Ng WT; Lee AWM; Yiu HHY
Clin Transl Radiat Oncol; 2022 Mar; 33():83-92. PubMed ID: 35128087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]